Hypersensitivity Reactions to Taxanes: A Multicenter Study for Outcomes and Safety of Rapid Drug Desensitization
CONCLUSIONS: Our experience demonstrates a 100% success rate in completing the 255 RDDs for taxanes, affirming the safety and efficacy of the RDD within the study population.PMID:38528382 | PMC:PMC10973638 | DOI:10.4168/aair.2024.16.2.142
Source: Allergy, Asthma and Immunology Research - Category: Allergy & Immunology Authors: Makbule Seda Bayrak Durmaz Done Gulcin Unutmaz Meryem Demir Ozlem Goksel Adile Berna Dursun Sevim Bavbek Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Cancer & Oncology | Docetaxel | Skin | Statistics | Study | Taxotere